Furnace G, Hamilton C A, Reid J L, Sumner D J
J Auton Pharmacol. 1985 Mar;5(1):13-7. doi: 10.1111/j.1474-8673.1985.tb00560.x.
The densities of [3H]-prazosin and [3H]-clonidine binding sites were determined in spleen and brain membrane preparations from rabbits treated 1 to 48 h previously with benextramine (5 mg/kg). In other rabbits pressor responses to phenylephrine and BHT 920 were examined 1 to 72 h after benextramine administration. After benextramine there was a reduction in the density of both [3H] prazosin and [3H] clonidine binding sites in spleen and a non-parallel shift in pressor dose response curves to selective alpha 1- and alpha 2-adrenoreceptor agonists. Recovery of in vivo responses and binding site densities were relatively slow. No reduction in the maximum density of either [3H] prazosin or [3H] clonidine binding sites in brain was found after intravenous administration of benextramine. It is concluded that after intravenous administration benextramine binds irreversibly to peripheral alpha 1- and alpha 2-adrenoreceptors in the rabbit but fails to cross the blood brain barrier in appreciable quantities and bind to central alpha-adrenoreceptors. Recovery of in vivo responses was more rapid than that previously observed after alpha-adrenoreceptor blockade with phenoxybenzamine. The longer time course of recovery after phenoxybenzamine may be a result of redistribution of this lipophilic drug from fat.
测定了事先用苄非他明(5毫克/千克)处理1至48小时的家兔脾脏和脑膜制剂中[3H]-哌唑嗪和[3H]-可乐定结合位点的密度。在其他家兔中,于苄非他明给药后1至72小时检测了对去氧肾上腺素和BHT 920的升压反应。苄非他明给药后,脾脏中[3H]哌唑嗪和[3H]可乐定结合位点的密度均降低,对选择性α1和α2肾上腺素能受体激动剂的升压剂量反应曲线发生非平行性偏移。体内反应和结合位点密度的恢复相对较慢。静脉注射苄非他明后,未发现脑中[3H]哌唑嗪或[3H]可乐定结合位点的最大密度降低。得出的结论是,静脉注射苄非他明后,它在兔体内与外周α1和α2肾上腺素能受体不可逆结合,但未能大量穿过血脑屏障并与中枢α肾上腺素能受体结合。体内反应的恢复比先前用酚苄明进行α肾上腺素能受体阻断后观察到的情况更快。酚苄明后恢复时间较长可能是由于这种亲脂性药物从脂肪中重新分布所致。